[Hypoxia-inducible factor-1alpha: a promising target for tumor therapy].

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Hypoxia-inducible factor-1alpha (HIF-1alpha), a nuclear transcriptional factor, is constitutively expressed in mammalian cells under hypoxia, which contributes a lot to the regulation of internal O2 homeostasis. Micro-environmental hypoxia is a common feature of solid tumors. Under the stress of hypoxia, HIF-1alpha is accumulated and activated, which leads to activation of a vast array of downstream genes that contribute to tumor O2 homeostasis and energy metabolic equilibrium. HIF-1alpha weighs heavily in favor of tumor genesis and progression. So far, HIF-1alpha has became an attracting tumor research topic, which improves understanding on how HIF-1alpha functions in tumor progression and key signaling pathways that regulate HIF-1alpha, therefore, provides new scientific supports and ideas to look for novel target for tumor therapy.

Cite

CITATION STYLE

APA

Tang, B. Z., Zhao, F. Y., Qu, Y., & Mu, D. Z. (2009). [Hypoxia-inducible factor-1alpha: a promising target for tumor therapy]. Ai Zheng = Aizheng = Chinese Journal of Cancer. https://doi.org/10.5732/cjc.008.10770

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free